Wednesday, June 10, 2026
🇺🇸 FDA

Patent directory · USPTO A61K / A61P

Patents matching “BIOPROJET PHARMA [FR]”

7 pharma patents match "BIOPROJET PHARMA [FR]" in our USPTO index (A61K/A61P) — applicant, grant date, expiration, and drug links.

Matches 7
Index total 30,257
Page 1 / 1

Quick answer

This filtered view shows 7 pharmaceutical patents matching "BIOPROJET PHARMA [FR]" in our USPTO PatentsView index (CPC A61K/A61P). Search matches patent number, title, applicant, and CPC classification codes.

Patent results

7 results for “BIOPROJET PHARMA [FR]” · 30,257 patents in full index Clear search

  1. EP 4732903

    COKRISTALLE VON PITOLISTANTHYDROCHLORID

    BIOPROJET PHARMA [FR] · Granted Apr 29, 2026 · Expires Apr 24, 2046

    granted

  2. EP 4681704

    NEUE FORMULIERUNGEN VON PITOLISANT

    BIOPROJET PHARMA [FR] · Granted Jan 21, 2026 · Expires Jan 16, 2046

    granted

  3. US 2025120959

    NEW FORMULATIONS OF PITOLISANT AND METHODS OF USE

    BIOPROJET PHARMA [FR] · Granted Apr 17, 2025 · Expires Apr 12, 2045

    granted

  4. US 2024327366

    POLYMORPH FORM OF PITOLISANT HYDROCHLORIDE

    BIOPROJET PHARMA [FR] · Granted Oct 3, 2024 · Expires Sep 28, 2044

    granted

  5. EP 3906927

    VERWENDUNG VON DOPAMIN-D3-TEILAGONISTEN ZUR BEHANDLUNG VON STÖRUNGEN DES ZENTRALEN NERVENSYSTEMS

    BIOPROJET PHARMA [FR] · Granted Nov 10, 2021 · Expires Nov 5, 2041

    granted

  6. US 2020024256

    TETRAHYDRATE OF H3 LIGAND, ITS PROCESS OF PREPARATION AND PHARMACEUTICAL COMPOSITIONS COMPRISING THE SAME

    BIOPROJET PHARMA [FR] · Granted Jan 23, 2020 · Expires Jan 18, 2040

    granted

  7. EP 3378477

    NEUE THERAPEUTISCHE VERWENDUNGEN VON H3-LIGANDEN

    BIOPROJET PHARMA [FR] · Granted Sep 26, 2018 · Expires Sep 21, 2038

    granted

Drug approvals, clinical trials, M&A, event intelligence, and company updates — weekly.

Customize topics & region
Topics
Region

No spam. Unsubscribe anytime. See our privacy policy.